Clara Hwang

Clara Hwang

Henry Ford Hospital - Detroit / United States
Others
AD Scientific Index ID: 4688331
person_outline Clara Hwang's MOST POPULAR ARTICLES
1-) Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial The Lancet Oncology 22 (7), 931-945, 2021
2-) hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes Molecular microbiology 18 (4), 715-727, 1995
3-) Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium Annals of oncology 32 (6), 787-800, 2021
4-) Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … The lancet oncology 23 (9), 1133-1144, 2022
5-) Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer Urology 53 (2), 260-266, 1999